1995
DOI: 10.1136/jcp.48.9.835
|View full text |Cite
|
Sign up to set email alerts
|

Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.

Abstract: Aims-To estimate the proportion and nature of the proliferating (Ki67+) circulating lymphocytes in a series ofpatients with multiple myeloma and monoclonal gammopathy of unknown significance (MGUS) and to correlate this with other clinical and laboratory parameters, using blood from healthy adults as a control. To investigate the extent to which the B and

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Conventional natural killer cell proliferation was measured after T. gondii infection by intracellular staining for nuclear Ki67, a marker of cell cycle progression and a surrogate marker of cellular proliferation ( 40 , 41 ). cNK cells did not appear to undergo proliferation at 5 days post infection in the PEC or spleen with any of the parasite strains tested (Figures 7 C,D).…”
Section: Resultsmentioning
confidence: 99%
“…Conventional natural killer cell proliferation was measured after T. gondii infection by intracellular staining for nuclear Ki67, a marker of cell cycle progression and a surrogate marker of cellular proliferation ( 40 , 41 ). cNK cells did not appear to undergo proliferation at 5 days post infection in the PEC or spleen with any of the parasite strains tested (Figures 7 C,D).…”
Section: Resultsmentioning
confidence: 99%
“…Ki‐67 has been shown to be exclusively expressed in the cells that have entered into G1, S, G2 and M phase of the cell cycle and is not expressed in resting cells [14–16]. The monoclonal antibody (MoAb) recognizing Ki‐67 has been widely used to assess the proliferation rate in a variety of malignant tumors [15, 17–19] and few studies have analyzed the expression of Ki‐67 in non‐neoplastic conditions [18, 20]. A two‐colour immunoenzymatic staining method with microwave heat treatment to increase the accessibility of the nuclear antigens was designed to identify the surface phenotype and nuclear expression of Ki‐67 simultaneously as described previously [21, 22].…”
Section: Introductionmentioning
confidence: 99%
“…MKI67 , AURKA , TOP2A and UBE2C were highly expressed in Ki67 + T cells, indicating an active proliferation status and potential contribution to the occurrence, development, and metastasis of UBC. Ki67 + T cell subsets were previously identified in colorectal cancer 36 and multiple myeloma 37 . Moreover, the percentage of Ki67 + lymphocytes was significantly higher in patients with multiple myeloma and monoclonal gammopathy compared with the normal controls, which was associated with disease stage.…”
Section: Discussionmentioning
confidence: 98%